Rats Get the Munchies Too, According to New Research
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchTHCNeurologyMental HealthSafetyAnxietyPain Why This Matters This research identifies the neurobiological basis…
In a First Episode of Psychosis (FEP), Distinct Symptoms, Cognition, and EEG Measures …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. Mental HealthResearchNeurologyTHCSafetyAnxietyDosing Clinical Summary This study examines neurobiological differences…
Cannabidiol Limits Early Aβ-Induced Glial Activation and Preserves Synaptic Integrity in …
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. CBDNeurologyResearchSafetyAgingMental HealthAnxiety Why This Matters Cannabidiol's demonstrated ability to…
Targeting cannabinoid receptors in bladder sensory pathways may alleviate pain of cystitis
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PainTHCResearchNeurologyCBDSafetyAnxiety Why This Matters This research identifies a potential mechanism for…
Controlling cystitis by targeting the source of pain with new therapies
✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PainTHCResearchNeurologySafetyDosingPolicy Why This Matters Clinicians managing interstitial cystitis or chronic urinary…
The Evolving Science of Cannabis Medicine
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDPainAnxietySafetyNeurologyMental Health Why This Matters Clinicians need to understand cannabidiol's…
Curaleaf International Launches CPD-Accredited Education Platform for UK Cannabis Prescribers
UK clinicians now have access to a CPD accredited cannabis education platform that fills critical gaps in medical cannabis prescribing knowledge. This education supports evidence-based practice for patient selection and dosing. The platform aims to…
France Sets July Deadline for Medical Cannabis Regulations, as Study Shows Opioid Reductions
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PolicyResearchPainNeurologyMental HealthSafetyDosing Why This Matters Clinicians treating patients with chronic pain…
Advancing the First Potential FDA-Approved Treatment for Cannabis Withdrawal
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchMental HealthSafetyPolicyIndustryAnxietyNeurology Why This Matters Clinicians currently lack FDA-approved…
PleoPharma Begins Phase 3 Trial for Cannabis Withdrawal Drug
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchMental HealthSafetyNeurologyDosingIndustryAnxiety Why This Matters Clinicians treating patients with cannabis use…
